Answers are grounded in this paper and cite their sources.
Introduction: Secondary fungal or bacterial infections or co-infections during the course of Covid 19 are important challenges increasing the patient’s morbidity and mortality. We have observed sudden rise of mucormycosis cases in post COVID 19 patients. Aims & Objective: To assess morbidity in operated cases of mucormycosis patients. Material & Methods: This study is cross sectional observational study which was conducted in the Department of ENT, B J Medical College & Civil Hospital, Ahmedabad, Gujarat, India. Data was collected from the 100 patients of mucormycosis. Results: In our study, most common complaint post operatively was headache. In our study only 16% of patients were complaint free where as 84% of patients had one or more complaints. Majority of our patients in the study had mild post-operative complaints. Conclusion: The results of the study showed that the overall quality of life of the patients improved significantly after surgery & medical management.Majority of the patients who survived mucormycosis remained with one or more post-operative complaints signifying debilitating nature of the disease & the devastating effect it can have on one’s quality of life.
No takes yet. Share an insight, caveat, or question.
Joshi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: